Market Overview:
Microfluidic systems are miniaturized devices that can precisely control the flow of fluids in channels that are typically 100 micrometers or less in width. Microfluidics has found a number of applications in life sciences and healthcare, laboratory research, and other industrial sectors. The global microfluidic systems market is expected to grow at a CAGR of 10.5% during the forecast period 2018-2030. The global microfluidic systems market by type is segmented into glass, polymer, and silicon based microfluidics systems. Glass-based microfludic devices currently dominate the market due to their low cost and easy fabrication process; however, polymer-based devices are gaining popularity due to their high flexibility and biocompatibility properties. Silicon-based devices offer superior performance with respect to accuracy and speed; however, they are expensive compared to other types of microfludic devices. The global microfludic systems market by application is segmented into healthcare diagnostics & therapeutics, laboratory research & development (R&D), food & beverage testing/analysis, environmental monitoring/testing etcetera).
Product Definition:
Microfluidic systems are miniature devices that use very small volumes of fluids for laboratory analysis, drug delivery and other applications. The devices can be as simple as a channel etched in a piece of silicon or as complex as an array of interconnected channels with multiple inlets and outlets. Microfluidic systems can be used to create miniaturized versions of traditional laboratory instruments or to develop new devices and analytical methods. Their small size and low cost make them attractive for use in point-of-care diagnostics, personalized medicine, environmental monitoring and other applications.
Glass:
Glass is a transparent, brittle, non-reactive material that can be used in microfluidic systems. It has the ability to flow at very high temperatures and has no taste or smell. Glass can withstand extremely high pressures as well. The most common types of glass used in microfluidics are borosilicate and silicon carbide (SiC).
Polymer:
Polymer is a substance that can be made up of repeated units connected by strong bonds and which has properties such as elastomer, thermoplastic, or glass. Polymers are usually manufactured from basic chemicals including ethylene, vinylene, and butadiene.
Application Insights:
The others segment includes food, packaging, and automotive applications. The growth of the healthcare application is attributed to the increasing need for advanced diagnostic techniques in order to provide appropriate treatment for patients. In addition, an increase in R&D activities pertaining to microfluidic systems has led to an increased demand for laboratory-on-chips.
The healthcare segment accounted for a share of over 40% in 2017 owing to its ability to deliver high precision and throughput while handling complex samples with ease and efficiency. Furthermore, growing research & development activities related with microfluidics are further expected fuel product demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of microfluidic device manufacturers and research institutes in this region. The U.S.-based companies are engaged in continuous R&D activities for developing innovative products based on microfluidics platform. Moreover, increasing investments by private firms and government agencies for commercializing novel technologies are also contributing toward regional growth.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising healthcare expenditure, increasing disposable income levels, and growing awareness about early diagnosis of chronic diseases among people living in this region as well as worldwide (CDC 2016). In addition, an increase in funding from public & private entities is anticipated to boost industry development across countries such as China & Japan during the forecast period (2016-2030).
Growth Factors:
- Increasing demand for miniaturization in various industries is driving the growth of microfluidic systems market.
- Rising prevalence of chronic diseases is also propelling the demand for microfluidic systems as they help in early diagnosis and treatment of diseases.
- Growing popularity of personalized medicine is also fueling the growth of microfluidic systems market as these systems are used to develop customized therapies for patients.
- increasing R&D spending by pharmaceutical and biotechnology companies on novel drug discovery and development is also contributing to the growth of microfluidic systems market . 5) technological advancements in fabrication techniques and materials are providing new opportunities for expansion into untapped markets, thereby driving the growth prospects for this market
Scope Of The Report
Report Attributes
Report Details
Report Title
Microfluidic Systems Market Research Report
By Type
Glass, Polymer, Silicon
By Application
Healthcare, Laboratory, Others
By Companies
Abbott Laboratories, Agilent Technologies, BD, Bio-Rad Laboratories, Cepheid, Dolomite, Fluidigm Corporation, Johnson & Johnson, Micronit Microfluidics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Microfluidic Systems Market Report Segments:
The global Microfluidic Systems market is segmented on the basis of:
Types
Glass, Polymer, Silicon
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Healthcare, Laboratory, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Agilent Technologies
- BD
- Bio-Rad Laboratories
- Cepheid
- Dolomite
- Fluidigm Corporation
- Johnson & Johnson
- Micronit Microfluidics
Highlights of The Microfluidic Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glass
- Polymer
- Silicon
- By Application:
- Healthcare
- Laboratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microfluidic Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microfluidic systems are miniature devices that can be used to control the flow of fluids and other materials. They are often used in research and development, manufacturing, and medical applications.
Some of the key players operating in the microfluidic systems market are Abbott Laboratories, Agilent Technologies, BD, Bio-Rad Laboratories, Cepheid, Dolomite, Fluidigm Corporation, Johnson & Johnson, Micronit Microfluidics.
The microfluidic systems market is expected to register a CAGR of 10.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Microfluidic Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Microfluidic Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Microfluidic Systems Market - Supply Chain
4.5. Global Microfluidic Systems Market Forecast
4.5.1. Microfluidic Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Microfluidic Systems Market Size (000 Units) and Y-o-Y Growth
4.5.3. Microfluidic Systems Market Absolute $ Opportunity
5. Global Microfluidic Systems Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Microfluidic Systems Market Size and Volume Forecast by Type
5.3.1. Glass
5.3.2. Polymer
5.3.3. Silicon
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Microfluidic Systems Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Microfluidic Systems Market Size and Volume Forecast by Application
6.3.1. Healthcare
6.3.2. Laboratory
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Microfluidic Systems Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Microfluidic Systems Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Microfluidic Systems Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Microfluidic Systems Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Microfluidic Systems Demand Share Forecast, 2019-2026
9. North America Microfluidic Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Microfluidic Systems Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Microfluidic Systems Market Size and Volume Forecast by Application
9.4.1. Healthcare
9.4.2. Laboratory
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Microfluidic Systems Market Size and Volume Forecast by Type
9.7.1. Glass
9.7.2. Polymer
9.7.3. Silicon
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Microfluidic Systems Demand Share Forecast, 2019-2026
10. Latin America Microfluidic Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Microfluidic Systems Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Microfluidic Systems Market Size and Volume Forecast by Application
10.4.1. Healthcare
10.4.2. Laboratory
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Microfluidic Systems Market Size and Volume Forecast by Type
10.7.1. Glass
10.7.2. Polymer
10.7.3. Silicon
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Microfluidic Systems Demand Share Forecast, 2019-2026
11. Europe Microfluidic Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Microfluidic Systems Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Microfluidic Systems Market Size and Volume Forecast by Application
11.4.1. Healthcare
11.4.2. Laboratory
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Microfluidic Systems Market Size and Volume Forecast by Type
11.7.1. Glass
11.7.2. Polymer
11.7.3. Silicon
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveess/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Microfluidic Systems Demand Share, 2019-2026
12. Asia Pacific Microfluidic Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Microfluidic Systems Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Microfluidic Systems Market Size and Volume Forecast by Application
12.4.1. Healthcare
12.4.2. Laboratory
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Microfluidic Systems Market Size and Volume Forecast by Type
12.7.1. Glass
12.7.2. Polymer
12.7.3. Silicon
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Microfluidic Systems Demand Share, 2019-2026
13. Middle East & Africa Microfluidic Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Microfluidic Systems Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Microfluidic Systems Market Size and Volume Forecast by Application
13.4.1. Healthcare
13.4.2. Laboratory
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Microfluidic Systems Market Size and Volume Forecast by Type
13.7.1. Glass
13.7.2. Polymer
13.7.3. Silicon
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Microfluidic Systems Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Microfluidic Systems Market: Market Share Analysis
14.2. Microfluidic Systems Distributors and Customers
14.3. Microfluidic Systems Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Agilent Technologies
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BD
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bio-Rad Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cepheid
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Dolomite
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Fluidigm Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Johnson & Johnson
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Micronit Microfluidics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
